Cargando…
Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
With the recent progress in imaging technologies for assessment of structural damage in glaucoma, a debate has emerged on whether these measurements can be used as valid surrogate endpoints in clinical trials evaluating new therapies for the disease. A discussion of surrogates should be grounded on...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455347/ https://www.ncbi.nlm.nih.gov/pubmed/28475699 http://dx.doi.org/10.1167/iovs.17-21987 |